Erika Carmel-Tech Ltd (TLV:ERKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 43.00
-1.10 (-2.49%)
Sep 1, 2026, 5:24 PM IDT
Erika Carmel-Tech Revenue
Erika Carmel-Tech had revenue of 16.57M ILS in the half year ending December 31, 2025, with 20.25% growth. This brings the company's revenue in the last twelve months to 33.43M, down -15.66% year-over-year. In the year 2025, Erika Carmel-Tech had annual revenue of 37.34M, down -1.64%.
Revenue (ttm)
33.43M
Revenue Growth
-15.66%
P/S Ratio
0.55
Revenue / Employee
742.80K
Employees
45
Market Cap
18.37M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.34M | -621.00K | -1.64% |
| Dec 31, 2024 | 37.96M | 8.08M | 27.03% |
| Dec 31, 2023 | 29.88M | -20.44M | -40.62% |
| Dec 31, 2022 | 50.32M | -46.53M | -48.04% |
| Dec 31, 2021 | 96.86M | 11.08M | 12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 180.82M |
| Identi Healthcare | 10.93M |
| Evogene | 4.94M |
| Can-Fite BioPharma | 1.29M |
| BioLight Life Sciences | 21.00K |